Exploring the Effects of WJ-MSC-Derived Exosomes on the Viability and Metabolic Activity of Lung, Pancreatic and Liver Cancer Cells
Open Access
- 31 December 2025
- journal article
- Published by Istanbul Gelisim University in İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi
- No. 27,p. 824-836
Abstract
Aim: Mesenchymal stem cells (MSCs) act on cancer cells in the same microenvironment by secreting cytokines, chemokines, exosomes, or by direct contact. The purpose of this study is to analyse the impact of WJ-MSC-derived exosomes on the viability and metabolic activity of lung, pancreatic, and liver cancer cells. Method: In this study, Wharton's Jelly (WJ)-MSCs-derived exosomes were added to A549, Panc-1, and HepG2 cells as 1-5-10-15 and 20 million particle exosomes. The effects on viability were evaluated by MTT analysis at 48 and 96 hours. The effects on metabolic activity were evaluated by calcein staining at the end of the 96th hour. Cell metabolic activity was calculated using fluorescence intensity. Results: At the end of the 96th hour, 62% increase in A549 cells, 95% increase in Panc-1 cells and 67% increase in HepG2 cells were detected in the control group. In the group which 20 million exosomes were applied, 36% increase in A549 cells, 43% increase in Panc-1 cells and 31% increase in HepG2 cells were observed. The fluorescence intensity of 20 million exosomes was calculated as: A549: 61%, Panc-1: 64% and HepG2: 68%. Preliminary findings indicate that WJ-MSC-derived exosomes do not increase the viability and metabolic activity of cancer cells when applied to them. It was also shown that the viability and metabolic activity can decrease depending on time and concentration. Conclusion: WJ-MSC-derived exosomes may be effective on cell viability and metabolic activity in vitro in tumors with high stroma content, and their effects on other mechanisms on tumor cells need to be investigated.Keywords
This publication has 30 references indexed in Scilit:
- The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell linesScientific Reports, 2022
- Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancerCancer Medicine, 2019
- microRNA‐16‐5p‐containing exosomes derived from bone marrow‐derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2Journal of Cellular Physiology, 2019
- Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progressionCancer Letters, 2019
- Effect of mesenchymal stem cells‐derived exosomes on tumor microenvironment: Tumor progression versus tumor suppressionJournal of Cellular Physiology, 2018
- Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathwayCytotherapy, 2018
- Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug deliveryJournal of Controlled Release, 2014
- Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell modelMolecular and Cellular Biochemistry, 2013
- Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivoCancer Letters, 2012
- Biology of mesenchymal stem cellsInjury, 2005